Minuet 发表于 2025-3-25 03:49:00

http://reply.papertrans.cn/59/5893/589225/589225_21.png

分开 发表于 2025-3-25 10:34:22

http://reply.papertrans.cn/59/5893/589225/589225_22.png

acolyte 发表于 2025-3-25 13:22:18

http://reply.papertrans.cn/59/5893/589225/589225_23.png

合唱团 发表于 2025-3-25 15:59:39

Emili Montserrat MDds: HRD, HRM, and management and leadership studies. It is an essential read for academic audiences who recognize leadership development as a dominant trend both in developed and emerging economies..978-1-349-95426-1978-1-137-58003-0Series ISSN 2662-1185 Series E-ISSN 2662-1193

Fortuitous 发表于 2025-3-25 23:05:47

https://doi.org/10.1007/978-1-62703-408-1B Cell; Cancer; Hodgkin; Lymphoma; Monoclonal Antibodies; Non-Hodgkin; Stem Cell Transplant; T Cell

言外之意 发表于 2025-3-26 01:12:51

http://reply.papertrans.cn/59/5893/589225/589225_26.png

朝圣者 发表于 2025-3-26 07:41:02

Lymphoma978-1-62703-408-1Series ISSN 2364-1134 Series E-ISSN 2364-1142

高歌 发表于 2025-3-26 11:08:03

http://reply.papertrans.cn/59/5893/589225/589225_28.png

ABIDE 发表于 2025-3-26 14:45:19

Current Clinical Oncologyhttp://image.papertrans.cn/l/image/589225.jpg

jet-lag 发表于 2025-3-26 18:12:55

2364-1134 indicators, prognostic factors, and treatment of firstline d.Recently, understanding the molecular pathogenesis of malignant lymphomas has led to improvement in the diagnostic precision and to the identification of a variety of molecular therapeutic targets. In addition, new drugs have been approved
页: 1 2 [3] 4 5 6 7
查看完整版本: Titlebook: Lymphoma; Diagnosis and Treatm Anas Younes,Bertrand Coiffier Book 2013 Springer Science+Business Media, LLC 2013 B Cell.Cancer.Hodgkin.Lymp